8-K
Current Report
Aclaris Therapeutics, Inc. Filed Acc 0001558370-23-010719
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading acrs-20230526x8k.htm…